AT406 (SM-406)

AT406 (SM-406) (订货以英文为准)

编号:A126412
CAS号:1071992-99-8
分子式:C32H43N5O4
分子量:561.71
货号 品牌 包装 目录价 您的价格 库存 数量 购买
A126412-5mg 阿拉丁 5mg ¥854.90
A126412-50mg 阿拉丁 50mg ¥4999.90
A126412-10mg 阿拉丁 10mg ¥1411.90
A126412-100mg 阿拉丁 100mg ¥9268.90
A126412-25mg 阿拉丁 25mg ¥2872.90
产品名称 AT406 (SM-406)
中文名称 AT406 (SM-406)
CAS号 1071992-99-8
分子式(M.F.) C32H43N5O4
分子量(M.W.) 561.71
储存条件 -20°C储存
溶解性DMSO 100 mg/mL Water <1 mg/mL Ethanol 100 mg/mL
存贮条件储存温度-20°C
备注AT406 (SM-406, ARRY-334543) is a potent Smac mimetic and an antagonist of IAP (inhibitor of apoptosis protein via E3 ubiquitin ligase), binding to XIAP-BIR3, cIAP1-BIR3 and cIAP2-BIR3 with Ki of 66.4 nM, 1.9 nM, and 5.1 nM, 50- to
生化机理AT-406 (formerly known as SM-406) is an orally bioavailable potent IAP (inhibitor of apoptosis protein) of XIAP, cIAP1, and cIAP2 with Ki of 66.4 nM, 1.9 nM, and 5.1 nM, respectively. This may restore and promote the induction of apoptosis through apoptotic signaling pathways. AT-406 may work synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. IAPs are overexpressed by many cancer cell types, suppressing apoptosis by binding and inhibiting active caspases-3, -7 and -9 via their BIR (baculoviral lAP repeat) domains. AT-406 is currently in Phase I clinical trial in patients with advanced solid tumors and lymphomas.
别名(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxo-decahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide;(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxo-decahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 950.00 sh113-100m
CAS号:9025-82-5
¥ 2428.00 P3243-1VL-1个
CAS号:4655-70-3
¥ 1156.00 BD01805572 -100mg
CAS号:14399-63-4
¥ 421.00 BD43576-250mg
¥ 11.00 jx112303-100张
CAS号:112-88-9
¥ 31.00 BD59946-100g
¥ 210.00 jx120423
CAS号:12017-01-5
¥ 310.00 C836018-5g
CAS号:102029-95-8
¥ 1150.00 A833596-1mg